Skip to main content

Table 2 Postoperative details

From: Myocardial protection with histidine-tryptophan-ketoglutarate solution in comparison with hypothermic hyperkalemic blood solution in the correction of acyanotic congenital heart diseases

 

Group

P*

HTK

HHB

Mean

±SD

Median

IQR

Mean

±SD

Median

IQR

ICU LOS (days)

2.80

0.71

3.00

2.00

3.00

3.20

0.76

3.00

3.00

4.00

0.04

Hospital LOS (days)

8.90

1.88

8.50

8.00

10.00

9.67

2.20

9.00

8.00

11.00

0.153

  1. ICU intensive care unit, LOS length of stay, HTK histidine-tryptophan-ketoglutarate, HHB hypothermic hyperkalemic blood, SD standard deviation, IQR interquartile range; *Student t test
  2. P value < 0.05 was considered significant